| First Author | Yang M | Year | 2023 |
| Journal | Immunity | Volume | 56 |
| Issue | 5 | Pages | 1013-1026.e6 |
| PubMed ID | 36944334 | Mgi Jnum | J:335621 |
| Mgi Id | MGI:7481877 | Doi | 10.1016/j.immuni.2023.02.015 |
| Citation | Yang M, et al. (2023) STING activation in platelets aggravates septic thrombosis by enhancing platelet activation and granule secretion. Immunity 56(5):1013-1026.e6 |
| abstractText | Sepsis is a dysregulated inflammatory consequence of systemic infection. As a result, excessive platelet activation leads to thrombosis and coagulopathy, but we currently lack sufficient understanding of these processes. Here, using the cecal ligation and puncture (CLP) model of sepsis, we observed septic thrombosis and neutrophil extracellular trap formation (NETosis) within the mouse vasculature by intravital microscopy. STING activation in platelets was a critical driver of sepsis-induced pathology. Platelet-specific STING deficiency suppressed platelet activation and granule secretion, which alleviated sepsis-induced intravascular thrombosis and NETosis in mice. Mechanistically, sepsis-derived cGAMP promoted the binding of STING to STXBP2, the assembly of SNARE complex, granule secretion, and subsequent septic thrombosis, which probably depended on the palmitoylation of STING. We generated a peptide, C-ST5, to block STING binding to STXBP2. Septic mice treated with C-ST5 showed reduced thrombosis. Overall, platelet activation via STING reveals a potential strategy for limiting life-threatening sepsis-mediated coagulopathy. |
